AI Tools Have Moderate-to-High Sensitivity for Chest Radiographs
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 27, 2023 -- Artificial intelligence (AI) tools show moderate-to-high sensitivity for detecting airspace disease, pneumothorax, and pleural effusion on chest radiographs, according to a study published online Sept. 26 in Radiology.
Louis Lind Plesner, M.D., from Herlev and Gentofte Hospital in Copenhagen, Denmark, and colleagues examined the diagnostic accuracy of four commercially available AI tools for detection of airspace disease, pneumothorax, and pleural effusion on chest radiographs in a retrospective study. A total of 2,040 patients comprised the dataset, and of these, 669 (32.8 percent) had target findings.
The researchers found that the AI tools demonstrated areas under the receiver operating characteristic curve ranging from 0.83 to 0.88, 0.89 to 0.97, and 0.94 to 0.97 for airspace disease, pneumothorax, and pleural effusion, respectively. The corresponding sensitivities ranged from 72 to 91 percent, 63 to 90 percent, and 62 to 95 percent. For all target findings, negative predictive values ranged from 92 to 100 percent. Specificity was high for chest radiographs with normal or single findings (range, 85 to 96 percent, 99 to 100 percent, and 95 to 100 percent for airspace disease, pneumothorax, and pleural effusion, respectively) and was markedly lower for chest radiographs with four or more findings (corresponding ranges, 27 to 69 percent, 96 to 99 percent, and 65 to 92 percent).
"Future studies could focus on prospective assessment of the clinical consequence of using AI for chest radiography in patient-related outcomes," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Survival Possible for Some With TBI for Whom Treatment Was Withdrawn
MONDAY, May 13, 2024 -- A substantial proportion of patients with traumatic brain injury (TBI) who undergo withdrawal of life-sustaining treatment (WLST) could have survived and...
Study Identifies Factors Associated With Hydroxychloroquine Retinopathy
MONDAY, May 13, 2024 -- Factors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney...
Adding Cardiovascular Biomarkers to Established Risk Factors Increases Risk Prediction
MONDAY, May 13, 2024 -- The addition of cardiovascular biomarkers to established risk factors leads to a small improvement in risk prediction of cardiovascular disease, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.